P Noris
Overview
Explore the profile of P Noris including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
374
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Frelinger 3rd A, Gachet C, Mumford A, Noris P, Mezzano D, Harrison P, et al.
J Thromb Haemost
. 2018 Oct;
16(11):2341-2346.
PMID: 30284374
No abstract available.
2.
Basciano P, Matakas J, Pecci A, Civaschi E, Cagioni C, Bompiani N, et al.
J Thromb Haemost
. 2014 Dec;
13(4):651-9.
PMID: 25529050
Background: Single nucleotide polymorphisms (SNPs) in platelet-associated genes partly explain inherent variability in platelet counts. Patients with monoallelic Bernard Soulier syndrome due to the Bolzano mutation (GPIBA A156V) have variable...
3.
Balduini C, Pecci A, Noris P
Hamostaseologie
. 2012 Sep;
32(4):259-70.
PMID: 22972471
The chapter of inherited thrombocytopenias has expanded greatly over the last decade and many "new" forms deriving from mutations in "new" genes have been identified. Nevertheless, nearly half of patients...
4.
Ageno W, Riva N, Noris P, Di Nisio M, La Regina M, Arioli D, et al.
J Thromb Haemost
. 2012 Aug;
10(11):2291-7.
PMID: 22925036
Background: Renal impairment is common, affecting around 40% of acutely ill medical patients, and is associated with an increased risk of both venous thromboembolism (VTE) and bleeding. The clinical benefit...
5.
Glembotsky A, Marta R, Pecci A, De Rocco D, Gnan C, Espasandin Y, et al.
J Thromb Haemost
. 2012 Jun;
10(8):1653-61.
PMID: 22672365
Background: Inherited thrombocytopenias (ITs) are heterogeneous genetic disorders that frequently represent a diagnostic challenge. The requirement of highly specialized tests for diagnosis represents a particular problem in resource-limited settings. To...
6.
Noris P, Klersy C, Zecca M, Arcaini L, Pecci A, Melazzini F, et al.
J Thromb Haemost
. 2009 Sep;
7(12):2131-6.
PMID: 19740094
Background: Distinguishing inherited thrombocytopenias from immune thrombocytopenia (ITP) can be difficult, and patients are therefore at risk of misdiagnosis and inappropriate treatments. Although it is known that the most common...
7.
Balduini A, Malara A, Pecci A, Badalucco S, Bozzi V, Pallotta I, et al.
J Thromb Haemost
. 2008 Dec;
7(3):478-84.
PMID: 19067792
Background: Although mutations of GPIb alpha are among the most frequent causes of inherited platelet disorders, the mechanisms for the onset of thrombocytopenia and platelet macrocytosis are still poorly defined....
8.
Canobbio I, Noris P, Pecci A, Balduini A, Balduini C, Torti M
J Thromb Haemost
. 2005 May;
3(5):1026-35.
PMID: 15869600
MYH9-related disease (MYH9-RD) is an autosomal dominant disorder deriving from mutations in the MYH9 gene encoding for the heavy chain of non-muscle myosin IIA, and characterized by thrombocytopenia and giant...
9.
Rampino T, Marasa M, Malvezzi P, Soccio G, Roscini E, Gamba G, et al.
Transplant Proc
. 2004 Apr;
36(3):700-2.
PMID: 15110636
Sirolimus is currently used to prevent rejection of solid organ transplant, and sirolimus-eluting stents have shown promise for the prevention of coronary artery restenosis. Thrombocytopenia is a well-known adverse effect...
10.
Balduini C, Salvaneschi L, Klersy C, Noris P, Mazzucco M, Rizzuto F, et al.
Leukemia
. 2001 Dec;
15(12):1885-91.
PMID: 11753609
Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) always require platelet transfusions, but the increase in platelet count is often less than expected. Since factors responsible for poor response to...